Résistance aux antibiotiques

Antibiotic resistance

Antibiotic resistance renders one or more antibiotics ineffective against a bacterial infection. This phenomenon can make it difficult, or even impossible, to treat certain infections.

Our missions

  • Monitoring the epidemiological trends of antibiotic-resistant bacteria

  • Issuing alerts in response to any unusual or concerning situation

  • Enabling the adaptation of preventive measures

  • Informing the general public

Contribution to International Monitoring and Initiatives

France’s contribution—through Santé publique France and its partners—to European surveillance of antibiotic resistance in human health underscores its commitment to combating antibiotic resistance beyond France’s borders.

European Surveillance of Bacterial Antibiotic Resistance: The EARS-Net Network

Santé publique France coordinates France’s participation in the European Antimicrobial Resistance Surveillance Network (EARS-Net), led by the European Centre for Disease Prevention and Control (ECDC). As the “National Focal Point,” the agency represents France within this network.

EARS-Net monitors antibiotic resistance in seven bacterial species isolated from blood cultures and cerebrospinal fluid: 

  • Staphylococcus aureus, 
  • Streptococcus pneumoniae, 
  • Escherichia coli, 
  • Enterococcus faecalis and Enterococcus faecium 
  • Klebsiella pneumoniae, 
  • Pseudomonas aeruginosa 
  • Acinetobacter baumannii. 

Among these bacteria, Streptococcus pneumoniae is primarily community-acquired (contracted outside of healthcare settings), while the others can be both community-acquired and nosocomial (contracted in a hospital or healthcare facility).

Since 2021, French data submitted to EARS-Net have come from the National Reference Center for Pneumococcus and the national Spares mission for the surveillance and prevention of antibiotic resistance in healthcare facilities. 

European Surveillance of Antibiotic Use: the ESAC-Net Network

Since late 2018, Santé Publique France has represented France within the ESAC-Net network as the “National Focal Point.” This network, coordinated by the ECDC, is tasked with monitoring the use of anti-infective agents in Europe, both in the community (outpatient sector) and in hospitals. In collaboration with the French National Agency for Medicines and Health Products Safety (ANSM), Santé Publique France is also responsible for submitting annual data on the use of anti-infective drugs to the ECDC.